SCN5A and familial long QT syndrome: Mexiletine belongs to class IB antiarrhythmic agents, previous studies reported that mexiletine exerted a direct effect on LQTS mutations and modified Nav1.5 mutation currents (Kim et al., 2019; Li et al., 2020).